ClinicalTrials.gg
Sign In
RecruitingNCT07592728BITE-IUpdated Jun 17, 2026

Brief Inhibitory Training for Eating - Intervention

An interventional study of Daily inhibitory control training in Overweight and/or Obesity, sponsored by George Mason University. Recruiting at 1 site in United States. Open to participants aged 14 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by George Mason University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
14 Years to 17 Years
Sex
All
01

Study summary

The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training.

Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life.

Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.

In the study, participants will:

Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone

02

Conditions studied

  • Overweight and/or Obesity

Keywords

  • obesity
  • adolescent
  • nutrition
  • eating behavior
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 36 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

George Mason University is the lead sponsor of 43 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 14-17 years old
  • Have overweight or obesity (-z≥85th percentile)
  • Have a smartphone
  • Can read and speak English
  • Interest in improving one's diet.

Exclusion criteria

Exclusion Criteria:

  • Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks
  • Not meeting criteria for atypical anorexia nervosa or bulimia nervosa
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Inhibitory control training

    Behavioral: Daily inhibitory control training

Interventions

  • BehavioralDaily inhibitory control training

    Children will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks

06

What researchers measure

Primary outcomes

  1. Inhibitory control

    Go-No/Go Task with food cues

    Time frame: 1 month

  2. Eating self-regulation

    Self-Regulation of Eating Behaviour Questionnaire

    Time frame: 1 month

Secondary outcomes

  1. Binge-eating symptoms

    Eating Pathology Symptom Inventory

    Time frame: 1 month

  2. Diet Quality

    Mini-EAT

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All IPD collected throughout the trial

Supporting information: Study protocol, Informed consent form

Time frame: June 2027 for an indefinite time period

Access criteria: Anyone

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Feb 2027, 9 months after the start.

Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 9 months is below that.

Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2026
First posted
May 18, 2026
StartActual
May 1, 2026
Primary completionEst.
Feb 10, 2027
CompletionEst.
Mar 10, 2027
Last update
Jun 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07592728
Lead sponsor
George Mason University
Responsible party
Tyler B Mason (Associate Professor, George Mason University) — Principal investigator
First posted
May 18, 2026
Start date
May 1, 2026
Primary completion
Feb 10, 2027 (estimated)
Completion
Mar 10, 2027 (estimated)
Last update
Jun 17, 2026

Study contacts

Tyler Mason, PhD
Contact
tmason24@gmu.edu
703-993-1000
Tyler Mason, PhD
principal investigator · George Mason University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Obesity →

Other studies from this sponsor

George Mason University

Start the discussion